Private company

PharMerica

Publicly traded American health care company

PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare's pharmacy business with a subsidiary of AmerisourceBergen. The company is headquartered in Louisville, Kentucky, and operates a major customer support center in Tampa, Florida.³ Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2007Founded¹

IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries¹
HeadquartersLouisville¹
Websitewww.pharmerica.com
Listed onNew York Stock Exchange¹
Incorporated inDE⁵
Business address4000 Metropolitan Dr, Orange, Ca 92868⁵
Legal formCorporation⁴
LEI549300SQV6IX7ZCVBD12⁴
StatusActive⁴
LEI statusLapsed (not renewed)⁴
Registered addressC/O Corporation Service Company, 19808 Wilmington, United States⁴
Registered withDivision of Corporations, Department of State, 4236312⁴

See how the biggest companies compare on our leaderboards

PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare's pharmacy business with a subsidiary of AmerisourceBergen.³

Leadership

Who has led PharMerica, and when. Pick a name to see everywhere that person has worked.

Chief executive

Gregory S. Weishar2007–2017

Chief financial officer

Chief operating officer

Mark A. McCullough2007

2010201520202025

Chief executive officerGregory S. Weishar Jul 16, 2007 to Dec 11, 2017⁶
Chief financial officerRobert E. Dries Feb 1, 2017 to Dec 8, 2017⁷
Chief financial officerDavid W. Froesel Jr. Apr 16, 2013 to Aug 2, 2016⁸
Chief financial officerMichael J. Culotta Jul 16, 2007 to Mar 27, 2013⁹
Chief operating officerMark A. McCullough Jul 16, 2007 to Aug 13, 2007¹⁰

Board members and other officers (20)

SVP Sales and Client ServicesMark Lindemoen Sep 27, 2012 to Mar 23, 2016¹¹
SVP and CTOSuresh Vishnubhatla Mar 23, 2011 to Dec 8, 2017¹²
EVPWilliam J. Monast Apr 22, 2009 to Jun 15, 2012¹³
Chief Information OfficerJohn Kernaghan Jul 31, 2008 to Jul 31, 2008¹⁴
SVP of HR, SecretaryAnthony Hernandez Jul 16, 2007 to Nov 15, 2013¹⁵
VP, Controller, PAOBerard Tomassetti Jul 16, 2007 to Dec 8, 2017¹⁶
SVP, Chief Clinical OfficerJanice D. Rutkowski Jul 16, 2007 to Mar 24, 2008¹⁷
SVP, Chief Information OfficerRichard Toole Jul 16, 2007 to Mar 24, 2008¹⁸
SVP, GC and SecretaryThomas A. Caneris Aug 23, 2007 to Dec 8, 2017¹⁹
Board memberPatrick G. Lepore Jan 14, 2013 to Dec 8, 2017²⁰
Board memberMarjorie W. Dorr Jan 26, 2009 to Dec 8, 2017²¹
Board memberGeoffrey G. Meyers Nov 19, 2009 to Dec 8, 2017²²
Board memberRobert A. Oakley Mar 25, 2008 to Dec 8, 2017²³
Board memberW. Robert Dahl Jr. Jul 28, 2008 to Dec 8, 2017²⁴
Board memberDaniel Newman Mendelson Jul 16, 2007 to May 28, 2010²⁵
Board memberDavid Yost Jul 16, 2007 to Aug 2, 2007²⁶
Board memberEdward L. Kuntz Jul 16, 2007 to Aug 9, 2007²⁷
Board memberGregory S. Weishar Jul 16, 2007 to Dec 11, 2017⁶
Board memberMahon Thomas P. Mac Jul 16, 2007 to Jun 21, 2016²⁸
Board memberThomas P. Gerrity Jul 16, 2007 to Jun 21, 2016²⁹

Former names

CAPSTONE PHARMACY SERVICES INCAug 8, 1996 to May 15, 1997⁵
CHOICE DRUG SYSTEMS INCJun 6, 1995 to Oct 16, 1995⁵

Timeline

Jul 16, 2007New chief executive Gregory S. Weishar becomes CEO⁶
2007Founded Founded¹

SEC filer profile

How PharMerica is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARPHARMERICA INC²
CIK0000792932
Employer ID (EIN)11-2310352²
Incorporated inDelaware²
Fiscal year endsSeptember 30²
Industry code (SIC)5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries²
Business address4000 Metropolitan Dr, Orange, CA 92868²
Phone7143854000²
On EDGAR sinceJun 6, 1995²
Filings129 in all: 8-K (21), 10-Q (12), S-8 (10), 8-K/A (8), S-4/A (8), S-3/A (7), SC 13G/A (7), SC 13G (6)²
All 32 form types
S-4 (5), SC 13D (5), SC 13D/A (5), 10-C (4), DEF 14A (4), 10-K (3), 10-K/A (3), S-3 (3), 424B3 (2), 424B4 (2), 10-K405/A (1), 10-Q/A (1), 10KT405 (1), 10KT405/A (1), 15-12G (1), 424B1 (1), 8-A12B (1), 8-A12G/A (1), DEFS14A (1), EFFECT (1), PRE 14A (1), PRER14A (1), PRES14A (1), S-8 POS (1)
Latest filingsAnnual report (10-K) Mar 15, 1999
Quarterly report (10-Q) Nov 16, 1998
Proxy statement (DEF 14A) Apr 28, 1998
Latest 8-K (8-K) Apr 22, 1999

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataPharMerica on Wikidata
2
SEC EDGARPharMerica filings on SEC EDGAR
3
WikipediaPharMerica on Wikipedia
4
GLEIFPharMerica LEI record (549300SQV6IX7ZCVBD12)
5
SEC EDGARPharMerica filings on SEC EDGAR
6
SEC EDGARGregory S. Weishar, Chief executive officer
7
SEC EDGARRobert E. Dries, Chief financial officer
8
SEC EDGARDavid W. Froesel Jr., Chief financial officer
9
SEC EDGARMichael J. Culotta, Chief financial officer
10
SEC EDGARMark A. McCullough, Chief operating officer
11
SEC EDGARMark Lindemoen, SVP Sales and Client Services
12
SEC EDGARSuresh Vishnubhatla, SVP and CTO
13
SEC EDGARWilliam J. Monast, EVP
14
SEC EDGARJohn Kernaghan, Chief Information Officer
15
SEC EDGARAnthony Hernandez, SVP of HR, Secretary
16
SEC EDGARBerard Tomassetti, VP, Controller, PAO
17
SEC EDGARJanice D. Rutkowski, SVP, Chief Clinical Officer
18
SEC EDGARRichard Toole, SVP, Chief Information Officer
19
SEC EDGARThomas A. Caneris, SVP, GC and Secretary
20
SEC EDGARPatrick G. Lepore, Board member
21
SEC EDGARMarjorie W. Dorr, Board member
22
SEC EDGARGeoffrey G. Meyers, Board member
23
SEC EDGARRobert A. Oakley, Board member
24
SEC EDGARW. Robert Dahl Jr., Board member
25
SEC EDGARDaniel Newman Mendelson, Board member
26
SEC EDGARDavid Yost, Board member
27
SEC EDGAREdward L. Kuntz, Board member
28
SEC EDGARMahon Thomas P. Mac, Board member
29
SEC EDGARThomas P. Gerrity, Board member